Corvus Pharmaceuticals, Inc. company logo
Corvus Pharmaceuticals, Inc. logo

Corvus Pharmaceuticals, Inc. (CRVS) EBITDA

Annual EBITDA

-$27.46M$4.21M-18.09%

Summary

Current Value
As of today, CRVS annual EBITDA is -$27.46M, down -18.09% on
Historical Performance
CRVS annual EBITDA is up +28.05% over the past 3 years, and up +42.92% over the past 5 years
All-Time High Comparison
CRVS annual EBITDA is currently -16957.76% below its historical high of -$161.00K set on
3-Year Low Comparison
CRVS annual EBITDA is +14.71% above its 3-year low of -$32.20M reached on an earlier date
Sector Comparison
CRVS annual EBITDA is higher than 41.67% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

CRVS Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA-$27.46M-18.1%+28.1%+42.9%-10000.0%
Quarterly EBITDA-$10.54M-45.7%+14.8%-8.7%-376.5%
TTM EBITDA-$38.76M-55.0%-16.3%+13.2%-1651.5%
Price$25.10+373.6%+3037.5%+519.8%
PE Ratio-
Annual Revenue$0.000.0%0.0%0.0%0.0%
Annual EPS-$1.02-81.5%+1.1%+35.8%-10000.0%
-$27.55M-17.7%+28.7%+43.6%-10000.0%
Annual Net Income-$62.29M-130.5%-44.1%-33.5%-10000.0%

EBITDA Highs

CRVS Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y-$23.26M-18.1%
5Y-$23.26M-18.1%
All-$161.00K>-9999.0%

EBITDA Lows

CRVS Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y-$32.20MN/A+14.7%
5Y-$43.13MN/A+36.3%
All-$55.68M+50.7%

EBITDA History

YearValueChange
-$27.46M-18.1%
-$23.26M+27.8%
-$32.20M+15.6%
-$38.17M+11.5%
-$43.13M+10.4%
-$48.11M+0.5%
YearValueChange
-$48.38M+13.1%
-$55.68M-53.0%
-$36.38M-167.1%
-$13.62M-8,360.9%
-$161.00K-

FAQ

  • What is the current annual EBITDA of CRVS?

    As of today, CRVS annual EBITDA is -$27.46M

  • What is 1-year change in CRVS annual EBITDA?

    CRVS annual EBITDA is down -18.09% year-over-year

  • What is 3-year change in CRVS annual EBITDA?

    CRVS annual EBITDA is up +28.05% over the past 3 years

  • How far is CRVS annual EBITDA from its all-time high?

    CRVS annual EBITDA is currently -16957.76% below its historical high of -$161.00K set on December 31, 2014

  • How does CRVS annual EBITDA rank versus sector peers?

    CRVS annual EBITDA is higher than 41.67% of companies in Healthcare sector

  • When is CRVS next annual earnings release?

    The next annual earnings release for CRVS is on

EBITDA Formula

EBITDA = + + +

Data Sources & References

  1. CRVS Official Website www.corvuspharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1626971/000110465925106259/0001104659-25-106259-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1626971/000155837025003621/0001558370-25-003621-index.htm
  4. CRVS Profile on Yahoo Finance finance.yahoo.com/quote/CRVS
  5. CRVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crvs